Involvement of cell adhesion molecules in polydatin protection of brain tissues from ischemia-reperfusion injury

被引:64
作者
Cheng, Yufang
Zhang, Han-Ting
Sun, Lisha
Gua, Shenglan
Ouyang, Shi
Zhang, Yanjun
Xu, Jiangping [1 ]
机构
[1] So Med Univ, Sch Pharmaceut Sci, Dept Pharmacol, Guangzhou 510515, Guangdong, Peoples R China
[2] W Virginia Univ, Hlth Sci Ctr, Dept Behav Med & Psychiat, Morgantown, WV 26506 USA
[3] W Virginia Univ, Hlth Sci Ctr, Dept Neurobiol & Anat, Morgantown, WV 26506 USA
基金
中国国家自然科学基金;
关键词
middle cerebral artery occlusion; ischemia reperfusion; polydatin; cell adhesion molecule;
D O I
10.1016/j.brainres.2006.06.065
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Previous studies have demonstrated that polydatin, a crystal component extracted from the root stem of the perennial herbage Polygonum Cuspidatum Sieb.et Zucc, exerts a neuroprotective effect on cerebral injury induced by ischemia/reperfusion. To investigate the possible mechanism of this action, we determined the effects of polydatin on the expression of cell adhesion molecules (CAMs) after ischemia-induced cerebral injury. Rats were treated with polydatin (i.v.) immediately after the operation of middle cerebral artery occlusion (MCAO) for 1 h. It was found that polydatin improved neurological deficits and reduced the volume of brain infarction. In addition, polydatin decreased the levels of CAMs relative to the control (MCAO alone); these included intercellular adhesion molecule-1 (ICAM-1), Vascular cell adhesion molecule-1 (VCAM-1), E-selectin, L-selectin and Integrins. These results suggest that polydatin exerts protective effects likely via inhibition of the expression of various CAMs; polydatin may be a potential agent for treatment of brain injury associated with stroke. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:193 / 200
页数:8
相关论文
共 41 条
[11]  
Huang Hai-xiao, 2003, Di Yi Jun Yi Da Xue Xue Bao, V23, P1253
[12]   Impact of interleukin-13 responsiveness on the synthetic and proliferative properties of Th1- and Th2-type pulmonary granuloma fibroblasts [J].
Jakubzick, C ;
Choi, ES ;
Kunkel, SL ;
Joshi, BH ;
Puri, RK ;
Hogaboam, CM .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (05) :1475-1486
[13]   Vascular cell adhesion molecule-1 mRNA is expressed in immune-mediated and ischemic injury of the rat nervous system [J].
Jander, S ;
Pohl, J ;
Gillen, C ;
Schroeter, M ;
Stoll, G .
JOURNAL OF NEUROIMMUNOLOGY, 1996, 70 (01) :75-80
[14]   Reperfusion injury after focal cerebral ischemia: The role of inflammation and the therapeutic horizon [J].
Jean, WC ;
Spellman, SR ;
Nussbaum, ES ;
Low, WC .
NEUROSURGERY, 1998, 43 (06) :1382-1396
[15]   Deficiency of intercellular adhesion molecule 1 attenuates microcirculatory disturbance and infarction size in focal cerebral ischemia [J].
Kitagawa, K ;
Matsumoto, M ;
Mabuchi, T ;
Yagita, Y ;
Ohtsuki, T ;
Hori, M ;
Yanagihara, T .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1998, 18 (12) :1336-1345
[16]   Regional and temporal expression patterns of interleukin-10, interleukin-10 receptor and adhesion molecules in the rat spinal cord during chronic relapsing EAE [J].
Ledeboer, A ;
Wierinckx, A ;
Bol, JGJM ;
Floris, S ;
de Lavalette, CR ;
De Vries, HE ;
van den Berg, TK ;
Dijkstra, CD ;
Tilders, FJH ;
Van Dam, AM .
JOURNAL OF NEUROIMMUNOLOGY, 2003, 136 (1-2) :94-103
[17]   Cell adhesion molecules as a marker reflecting the reduction of endothelial activation induced by glucocorticoids [J].
Leone, M ;
Boutière-Albanèse, B ;
Valette, S ;
Camoin-Jau, L ;
Barrau, K ;
Albanèse, J ;
Martin, C ;
Dignat-George, F .
SHOCK, 2004, 21 (04) :311-314
[18]   REVERSIBLE MIDDLE CEREBRAL-ARTERY OCCLUSION WITHOUT CRANIECTOMY IN RATS [J].
LONGA, EZ ;
WEINSTEIN, PR ;
CARLSON, S ;
CUMMINS, R .
STROKE, 1989, 20 (01) :84-91
[19]  
MACRAE IM, 1992, BRIT J CLIN PHARMACO, V34, P302
[20]   ROLE OF CELL-ADHESION MOLECULES IN BRAIN INJURY AFTER TRANSIENT MIDDLE CEREBRAL-ARTERY OCCLUSION IN THE RAT [J].
MATSUO, Y ;
ONODERA, H ;
SHIGA, Y ;
SHOZUHARA, H ;
NINOMIYA, M ;
KIHARA, T ;
TAMATANI, T ;
MIYASAKA, M ;
KOGURE, K .
BRAIN RESEARCH, 1994, 656 (02) :344-352